| 1 |
Partly verified |
Full text not readStored summary read |
N01 · Evidence conditionSelected 5% claim and original gradeRequired |
The selected subclaim is “At least 5% weight loss,” with grade C and a note of a secondary responder result of 40% versus 17%. Subclaim score/status/axes are absent; parent C56 is not used to fill the subclaim score. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Subclaim score, status and axes are absent. The primary mean endpoint and secondary responder endpoint are not combined. Existing content review remains incomplete. |
Distinction between the original responder question/grade and the parent mean-weight verdict |
A proposed follow-up comparison specifying the responder question and hierarchy; no new investigation, calculation or trial was performed. |
| 2 |
Partly verified |
Full text not readStored summary read |
N02 · Evidence conditionDefinition of the 5% thresholdRequired |
The original question concerns attaining the threshold of at least 5% weight loss. This is not converted into mean change in kg, individual final weight or change in every participant. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Reference weight/calculation formula, rounding/boundaries, evaluation windows, measurement selection and details of advance definitions remain unverified. Existing content review remains incomplete. |
Threshold, reference weight, calculation/time point and responder-adjudication rules |
A proposed follow-up study specifying thresholds, measurement and time points; no new investigation, calculation or trial was performed. |
| 3 |
Partly verified |
Full text not readStored summary read |
N03 · Evidence condition40% versus 17% and P valueRequired |
The original result was at least 5% weight loss in 40% versus 17%, P<0.001. No new proportion difference, RR/OR, NNT, CI or event count is calculated. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Analysis denominators/event counts for each proportion, exact test/model, CI and distinction between observed/estimated values remain unverified. Existing content review remains incomplete. |
Distinction between original proportions, group correspondence, P value and new arithmetic |
A proposed study reporting proportions together with uncertainty and denominators; no new investigation, calculation or trial was performed. |
| 4 |
Partly verified |
Full text not readStored summary read |
N04 · Evidence conditionResponder denominators and event countsRequired |
351 randomized participants (176/175) describe the original population. These are not multiplied by 40%/17% to create event counts or used to fill the effective denominator of each proportion. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Effective denominators for each proportion, responder counts, inclusion/exclusion and measured/estimated criteria remain unverified. Existing content review remains incomplete. |
Randomized, observed and model denominators and actual responder counts |
A proposed study reporting enrolled, observed and estimated denominators separately; no new investigation, calculation or trial was performed. |
| 5 |
Partly verified |
Full text not readStored summary read |
N05 · Evidence conditionProportion effects, CIs and precisionRequired |
Original proportions and P value are preserved. Proportion differences, relative effects, CIs or individual success probabilities unlinked in the manuscript are not newly created. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Planned effect measures, exact estimates, CIs and importance/success criteria remain unverified. Existing content review remains incomplete. |
Original proportions, prespecified effect measures, CIs and clinical importance |
A proposed follow-up study disclosing effect measures and uncertainty; no new investigation, calculation or trial was performed. |
| 6 |
Partly verified |
Full text not readStored summary read |
N06 · Evidence conditionMean change is a different endpointRequired |
Mean change of −4.0 kg versus −0.1 kg and a between-group difference of −3.8 kg (95% CI −5.0 to −2.5), P<0.001, form a separate primary endpoint. The 5% proportions, event counts or individual weight loss are not calculated from these. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Individual baseline/change distributions and data linking mean and responder outcomes remain unverified. Existing content review remains incomplete. |
Distinction between continuous means and threshold-attainment distributions/proportions |
A proposed follow-up trial distinguishing mean and responder endpoints; no new investigation, calculation or trial was performed. |
| 7 |
Partly verified |
Full text not readStored summary read |
N07 · Evidence conditionSecondary endpoint and prespecified hierarchyRequired |
The manuscript identifies at least 5% weight loss as a secondary responder result. This is not upgraded into a new primary endpoint, independent confirmatory trial or prespecified success threshold. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Pre-recruitment specification of responder definitions/analyses, test order, change history and estimation models remain unverified. Existing content review remains incomplete. |
Distinction between the primary mean endpoint and secondary 5% responder result |
A proposed study distinguishing the primary endpoint from prespecified responder analyses; no new investigation, calculation or trial was performed. |
| 8 |
Partly verified |
Full text not readStored summary read |
N08 · Evidence conditionMeasured weight and responder-adjudication valuesRequired |
Primary weight change used standardized measurement at research visits. This is distinguished from daily smart-scale/app entries and self-report; actual values/visit rules used for the 5% proportions are not filled in. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Measurement sources, evaluation windows, equipment/conditions and valid baseline/final values for responder adjudication remain unverified. Existing content review remains incomplete. |
Correspondence between visit weight, self-monitoring/self-report and proportion calculations |
A proposed study linking measured/remote measurements with responder calculations; no new investigation, calculation or trial was performed. |
| 9 |
Partly verified |
Full text not readStored summary read |
N09 · Evidence conditionPopulation, comorbidities and recruitmentRequired |
351 people aged 21–65 at community health centers had obesity and at least one of hypertension, diabetes or hyperlipidemia. This is not extended into the probability of attaining 5% loss in other populations. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Detailed eligibility, baseline weight/condition distributions, recruitment/exclusions and group balance remain unverified. Existing content review remains incomplete. |
Obese population aged 21–65 with baseline conditions and applicability scope |
A proposed follow-up study specifying applicability by population; no new investigation, calculation or trial was performed. |
| 10 |
Partly verified |
Full text not readStored summary read |
N10 · Evidence conditionAttribution within multicomponent TrackRequired |
The intervention bundled an app, cellular smart scale, 18 dietitian calls and clinician counseling. The proportion attaining 5% loss is not converted into an effect of a stand-alone app or a specific component. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Independent component effects, component-separation/combination designs and contributions of actual use remain unverified. Existing content review remains incomplete. |
The full bundle versus individual effects of app/counseling and other components |
A proposed follow-up comparison distinguishing bundle and component attribution; no new investigation, calculation or trial was performed. |
| 11 |
Partly verified |
Full text not readStored summary read |
N11 · Evidence conditionComponent plans and actual useRequired |
The manuscript records app self-monitoring/tailored feedback, daily cellular-scale weighing, 18 calls and counseling based on electronic-record recommendations. Plans are not used to imply actual completion by every participant. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Component-specific delivery/usage, adherence, discontinuation, contact intensity and differences in clinical/concurrent management remain unverified. Existing content review remains incomplete. |
Delivery/exposure for app feedback, daily scale use, 18 calls and clinical integration |
A proposed follow-up study distinguishing plans from actual exposure and response; no new investigation, calculation or trial was performed. |
| 12 |
Partly verified |
Full text not readStored summary read |
N12 · Evidence conditionUsual-care controlRequired |
The comparison involved 176 intervention participants versus 175 receiving usual care. Usual care is not described as no management/contact, and equal support in all respects is not established. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Control content, contact/support, additional programs, crossover use and baseline-condition management remain unverified. Existing content review remains incomplete. |
Actual control management, contact and additional-exposure conditions |
Proposed follow-up trial disclosing actual comparison conditions; no new investigation, calculation or trial was performed in this production. |
| 13 |
Partly verified |
Full text not readStored summary read |
N13 · Evidence condition12-month assessment, maintenance and regainRequired |
The responder result in the 12-month study context is preserved. Attaining the threshold once during follow-up, sustained attainment and maintenance/regain beyond 12 months are not made into the same outcome. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Exact evaluation windows, earlier responses, maintained attainment/regain and long-term/discontinuation follow-up remain unverified. Existing content review remains incomplete. |
Distinction between the selected responder time point and persistence during or beyond follow-up |
A proposed study reporting threshold attainment separately from maintenance/regain; no new investigation, calculation or trial was performed. |
| 14 |
Partly verified |
Full text not readStored summary read |
N14 · Evidence conditionRandomization and allocation concealmentRequired |
The manuscript records sequence generation by a statistician and concealment from study staff before allocation. It is not described as current original-source review or verification of allocation records. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Allocation records, implementation/exceptions, baseline balance and correspondence with the original protocol remain unread. Existing content review remains incomplete. |
Historical allocation-procedure narrative and current access to originals |
Proposed follow-up trial disclosing allocation procedures; no new investigation, calculation or trial was performed in this production. |
| 15 |
Partly verified |
Full text not readStored summary read |
N15 · Evidence conditionAssessor masking and participant expectationsRequired |
The manuscript records masked measurement staff and unmasked participants. This is not extended into verification of every responder-calculation/analysis role or exclusion of expectation effects. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Original materials on responder-adjudication/analysis roles, maintained masking and expectation/behavior effects remain unread. Existing content review remains incomplete. |
Scope of masking for outcome assessors and participants |
A proposed study distinguishing masking from participant behavior/expectation scope; no new investigation, calculation or trial was performed. |
| 16 |
Partly verified |
Full text not readStored summary read |
N16 · Evidence conditionITT and responder-analysis populationRequired |
The manuscript’s statement of following ITT is preserved. It is not automatically transferred into details of populations/handling used for the 5% proportions or verification of observation of all participants. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Responder-analysis inclusion/exclusion, actual population definitions, primary/sensitivity analyses and PPS correspondence remain unverified. Existing content review remains incomplete. |
Overall ITT principle versus actual denominators/populations for secondary proportions |
A proposed study separately disclosing analysis populations for continuous and responder outcomes; no new investigation, calculation or trial was performed. |
| 17 |
Partly verified |
Full text not readStored summary read |
N17 · Evidence conditionMaximum-likelihood missing data and proportion handlingRequired |
The manuscript’s prespecified-model maximum-likelihood estimation is preserved. This is not used as identical verification of missing-data handling or denominator rules for responder proportions. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Missing-data adjudication, imputation/estimation, nonresponse handling and model/sensitivity for the 5% result remain unverified. Existing content review remains incomplete. |
Distinction between primary-analysis missing-data estimation and handling of unobserved responders |
A proposed study reporting endpoint-specific missing-data handling and effects separately; no new investigation, calculation or trial was performed. |
| 18 |
Unverified |
Full text not readStored summary read |
N18 · Evidence conditionAttrition, non-observation and missed visitsRequired |
351 participants and 176/175 describe the randomized population. Without distinguishing observed/unobserved measurements and participant attrition, these are not used as outcomes for everyone or absence of missing-data effects. |
Information currently needed is unverified in the preserved summary. Visit/group-specific observed counts, attrition causes, response-related missingness and follow-up status remain unverified. Existing content review remains incomplete. |
Group-specific timing, causes and response effects of attrition/missingness |
A proposed follow-up study disclosing effects of non-observation and response adjudication; no new investigation, calculation or trial was performed. |
| 19 |
Partly verified |
Full text not readStored summary read |
N19 · Evidence conditionProportion tests, within/between groups and adjustmentRequired |
The group correspondence of 40% versus 17% and P<0.001 is preserved as recorded. Within-group changes or rounded proportions are not converted into new adjusted effects or event risk ratios. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Exact tests, models/covariates, observed/estimated proportions, adjustment/advance plans and CIs remain unverified. Existing content review remains incomplete. |
Proportion contrasts and original model, test and adjustment conditions |
A proposed study clearly reporting proportion estimands and tests; no new investigation, calculation or trial was performed. |
| 20 |
Partly verified |
Full text not readStored summary read |
N20 · Evidence conditionRegistration and advance responder plansRequired |
Original NCT01827800, posting on 2013-04-10 and allocation starting on 2013-06-18 are preserved. Prospective registration and agreement with the primary 12-month mean endpoint do not substitute for verification of all 5% analysis conditions. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Secondary responder plans/definitions, pre-recruitment SAP, change history and full registration remain unread. Existing content review remains incomplete. |
NCT identifier and scope of advance plans for primary/secondary proportion endpoints |
A proposed study openly linking registration with actual secondary analyses; no new investigation, calculation or trial was performed. |
| 21 |
Partly verified |
Full text not readStored summary read |
N21 · Evidence conditionMultiple outcomes, hierarchy and time pointsRequired |
5% is a secondary outcome distinct from mean weight. Success at multiple time points, blood-pressure/glucose/other outcomes or independent replication is not newly created. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Complete lists of secondary outcomes/time points, adjustment, hierarchy and analysis/reporting changes remain unverified. Existing content review remains incomplete. |
Multiplicity in testing responders and other time points/endpoints |
A proposed study separating primary endpoints from secondary proportions and other outcomes; no new investigation, calculation or trial was performed. |
| 22 |
Partly verified |
Full text not readStored summary read |
N22 · Evidence conditionThresholds, importance and disease eventsRequired |
The manuscript records no declared prespecified success threshold or externally validated minimum clinically important difference. The secondary 5% threshold is not repurposed as a trial-success boundary or reductions in blood pressure/glucose/disease events. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Evidence for threshold importance, advance success definitions and patient-important clinical/long-term outcomes remain unverified. Existing content review remains incomplete. |
Distinction between 5% response, advance success/importance criteria and clinical outcomes |
A proposed follow-up study distinguishing responders from clinical outcomes; no new investigation, calculation or trial was performed. |
| 23 |
Unverified |
Full text not readStored summary read |
N23 · Evidence conditionConcurrent management, medication and lifestyleRequired |
This bundled trial involved baseline conditions and clinician counseling. Absence of medication/diet/activity/contact differences or effects on attaining 5% loss is not assumed. |
Information currently needed is unverified in the preserved summary. Group-specific concurrent management/medication changes, lifestyle, additional support and their analyses remain unverified. Existing content review remains incomplete. |
Concurrent conditions/medication, lifestyle/clinical exposure and responder outcomes |
A proposed follow-up study distinguishing concurrent management from responder outcomes; no new investigation, calculation or trial was performed. |
| 24 |
Partly verified |
Full text not readStored summary read |
N24 · Evidence conditionNIH public supportRequired |
NIH NIDDK R01DK093829 provided support. This is not used as absence of all commercial/author relationships or new independence certification. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Funder/researcher roles, agreements, data/publication rights and complete disclosures remain unread. Existing content review remains incomplete. |
Distinction between funder/grant, support roles and independence |
Proposed follow-up trial disclosing support/research roles; no new investigation, calculation or trial was performed in this production. |
| 25 |
Partly verified |
Full text not readStored summary read |
N25 · Evidence conditionNon-reporting of support in the pivotal paperRequired |
The manuscript states that commercial sponsorship, donated scales, outsourced analysis, medical writing and publication-fee support were not reported in the pivotal paper. Non-reporting is not judged as actual absence of support. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Actual presence/scope of each support category, agreements, analysis/writing roles and original disclosures remain unread. Existing content review remains incomplete. |
Category-specific scope of commercial, in-kind, outsourced-analysis/writing and publication support |
A proposed study disclosing support categories distinctly; no new investigation, calculation or trial was performed. |
| 26 |
Partly verified |
Full text not readStored summary read |
N26 · Evidence conditionLater author relationships and disclosure timingRequired |
The original record places later-paper disclosures of Gary Bennett’s WW advisory role and equity in Coeus Health after the pivotal trial. Funding/COI during that trial are not retrospectively established. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Specific later bibliography, disclosure timing, relationships/agreements during the original trial and complete COI remain unlinked/unread. Existing content review remains incomplete. |
Distinction between later WW/Coeus disclosures and original-trial timing/roles |
A proposed study distinguishing relationship/support attribution by period; no new investigation, calculation or trial was performed. |
| 27 |
Partly verified |
Full text not readStored summary read |
N27 · Evidence conditionReferences to null results from other programsRequired |
References to null trials of app-only or low-intensity technology support limit generalization because composition/intensity differ. Those reports are not newly created or combined as direct refutations or independent replications of Track’s responder result. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Specific bibliography, populations, proportions/endpoints, denominators and results for other programs remain unlinked. Existing content review remains incomplete. |
Directness of Track’s bundle versus app-only/low-intensity programs |
A proposed direct follow-up comparison matching composition and intensity; no new investigation, calculation or trial was performed. |
| 28 |
Partly verified |
Full text not readStored summary read |
N28 · Evidence conditionSame report, sibling sheets and independenceRequired |
The 5% and mean sheets share the same Bennett2018 Track trial of 351 participants. Groups, time points, thresholds, bibliography/registration and sibling sheets are not added as new independent trials or participants. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Independent reproduction under the same bundle/responder conditions and unique clinical totals are not established. Existing content review remains incomplete. |
Mean/responder, report/registration and group/time-point relationships |
A proposed independent follow-up comparison specifying the same secondary threshold; no new investigation, calculation or trial was performed. |
| 29 |
Partly verified |
Full text not readStored summary read |
N29 · Evidence conditionPersistence and applicability to other compositions/populationsRequired |
The 12-month bundled trial’s responder result is not extended to all apps/products, other populations, maintenance after stopping the intervention or disease treatment. No new recommendations or weight-loss instructions are created. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Long-term/discontinuation follow-up, other compositions/populations and direct single-component comparisons remain unverified. Existing content review remains incomplete. |
Distinction between Track responder results and long-term/stand-alone-app/other-population effects |
A proposed study distinguishing threshold attainment from persistence/applicability; no new investigation, calculation or trial was performed. |
| 30 |
Partly verified |
Full text not readStored summary read |
N30 · Harm-information gaps supplementing the efficacy tableUnknown safety and collection gapsSupplementary |
The original record states that parent safety is unknown and adverse events from a prespecified safety endpoint were not systematically presented in the pivotal paper. Attaining 5% loss is not converted into absence of harm or treatment safety. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Adverse-event collection/adjudication, group-specific types/frequencies/denominators, discontinuation and vulnerable-population/long-term harms remain unverified. Existing content review remains incomplete. |
Prespecification, collection/denominators and follow-up for adverse events |
A proposed follow-up study specifying harm collection and follow-up; no new investigation, calculation or trial was performed. |
| 31 |
Partly verified |
Full text not readStored summary read |
N31 · Evidence conditionParent/subclaim, Korean/English, corrections and historyRequired |
Parent C56, B/S/R1/I2/E+/B0, unrecorded precision, three false flags, empty override reasons and subclaim grade C/note are preserved. Korean/English text, 2026-08-26, empty corrections/deliberation and historical cross-checking are not inherited as current review or a subclaim score. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. Absent subclaim score/status/axes are not filled with parent values, and no new certification is created. Existing content review remains incomplete. |
Separate preservation of original values/axes, reference dates and verification narratives |
Proposed research distinguishing original values/history from new-update scope; no new investigation, calculation or trial was performed in this production. |
| 32 |
Partly verified |
Full text not readStored summary read |
N32 · Evidence conditionSummary reading, external links and updatesRequired |
The full preserved JSON summary and bibliography were used for production, and links are retained. Papers, registration, protocol, SAP and original later disclosures/support materials remain unread with no access attempt; links were not tested. |
Only the relevant information in the preserved summary is recorded; detailed originals remain unread and existing content review incomplete. External originals, exact responder denominators/models and actual accessibility remain unverified. Existing content review remains incomplete. |
Actually read scope and access status of external materials |
A proposed study updating acquisition, timing and scope of materials separately; no new investigation, calculation or trial was performed. |